Inamul Hasan Madar | Medicine | Outstanding Scientist Award

Published on by Academic Excellence

Prof. Dr. Inamul Hasan Madar | Medicine | Outstanding Scientist Award

Prof. Dr. Inamul Hasan Madar | Medicine | Yenepoya Universtiy |India

Dr. Inamul Hasan Madar is a distinguished researcher and educator in the field of biochemistry with a specialization in oncology proteogenomics. He earned his PhD from Korea University, a globally ranked institution, and has since developed extensive expertise in cancer genomics, multiomics integration, and bioinformatics. With a strong commitment to advancing medical research, Dr. Madar has served as an adjunct faculty at Saveetha Medical College (SIMATS), where he has mentored PhD, MD, MBBS, and MSc students in cutting-edge biomedical sciences. His international research experience includes appointments at Korea University and Hanyang University in South Korea, where he contributed to high-impact oncology projects. As Director and Lead of Canary Oncoceutics India, he has bridged the gap between research and industry by leading innovative onco-therapeutic initiatives. Widely published in top-tier journals, Dr. Madar has also served as a reviewer for international journals and as a member of prestigious scientific societies worldwide.

Author profile

Orcid

Education

Dr. Madar’s academic journey reflects a deep pursuit of excellence in biomedical sciences. He earned his PhD in Biochemistry, specializing in Onco-Proteogenomics, from Korea University, Seoul, ranked among the top global universities. His doctoral work focused on proteogenomic profiling and cancer biomarker discovery, positioning him at the forefront of precision oncology. Before this, he pursued advanced training in bioinformatics, molecular biology, and proteomics, equipping him with multidisciplinary skills to tackle complex biomedical challenges. His postgraduate education emphasized molecular diagnostics and computational approaches, while his undergraduate studies laid the foundation in biochemistry and clinical applications. Dr. Madar has also completed specialized training programs in next-generation sequencing (NGS), computational modeling, molecular docking, and drug discovery pipelines. Furthermore, he has been actively engaged in faculty development programs, including pedagogy training for undergraduate teaching in life sciences and biotechnology. This comprehensive educational background underscores his ability to combine research innovation with academic excellence.

Experience

Dr. Madar’s professional experience spans academia, research, and industry. He currently serves as Adjunct Faculty at Saveetha Medical College, SIMATS, where he mentors MBBS, MD, MSc, MPhil, and PhD students in research methodologies, cancer biology, and bioinformatics. He is also Director and Lead (Marketing) at Canary Oncoceutics India, overseeing translational oncology research and innovation in oncoceutical product development. Internationally, he worked as a Visiting Scientist at Korea University, specializing in proteogenomics, and as a Researcher at Hanyang University, Seoul, in bioengineering. In India, his previous roles include Scientist & Course Coordinator at Biocuration, where he designed genomics and drug development modules, and Junior Scientist at iPro Technologies. He has also contributed as a guest lecturer at Bharathidasan University, training future biochemists. His expertise extends to designing computational pipelines, analyzing multiomics datasets, and leading cross-disciplinary projects that bridge laboratory science and clinical application, particularly in cancer therapeutics and biomarker discovery.

Awards and Honors

Dr. Inamul Hasan Madar has received widespread recognition for his contributions to biomedical research and education. His publications in high-impact journals such as Nature Cancer, Oncotarget, Briefings in Bioinformatics, and Molecular Cancer have positioned him among leading voices in proteogenomics and cancer research. He has served as a peer reviewer for several prestigious journals, including Nature’s Scientific Reports, Frontiers in Oncology, BMC Medical Genomics, and Journal of Translational Medicine. He has been actively involved in international professional societies, including the American Association of Cancer Research (AACR), American Society for Biochemistry and Molecular Biology (ASBMB), International Society of Computational Biology (ISCB), and South African and Korean Mass Spectrometry Societies. His leadership roles include serving as Vice President of ISCB-RSG India, demonstrating his dedication to strengthening scientific networks. He has also mentored numerous graduate and medical students, guiding them to publish impactful research, file patents, and develop translational medical applications.

Research Focus

Dr. Madar’s research focus lies at the intersection of cancer genomics, proteogenomics, and computational biology. He specializes in integrating multiomics datasets to identify novel biomarkers and therapeutic targets for treatment-resistant cancers, particularly cervical, prostate, and oral squamous cell carcinoma. His expertise in next-generation sequencing (RNA-Seq, Exome-Seq) and bioinformatics has enabled him to develop innovative pipelines for cancer biomarker discovery, molecular subtyping, and clinical variant interpretation. Beyond oncology, he has contributed to research in neurobiology, metabolic disorders, cardiovascular protection, and bioactive peptides against diabetes and obesity. His translational approach emphasizes the “bench-to-bedside” concept, applying computational models and molecular profiling to guide precision medicine strategies. Dr. Madar has also explored theranostic targets, signaling networks, and novel oncoceutical formulations. His interdisciplinary collaborations with international research groups have advanced drug design, CAR-T therapy applications, and personalized treatment strategies, positioning him as a pioneer in cancer research and translational medicine.

Publications

  • Correction to: Proteogenomic characterization of molecular and cellular targets for treatment-resistant cervical cancers.

  • Molecular analysis of HPV16 and HPV18 oncogenes in oral squamous cell carcinoma.

  • Proteogenomic characterization of treatment-resistant subtypes in cervical cancers.

  • Theranostic Target NSUN2 uncovered with systematic assembly of 805 datasets.

  • Unravelling the phosphoregulatory network of PKC-delta (PKC-δ).

  • BDNF-TrkB signalling: A neurotrophic pathway to cardiovascular protection.

  • Physiological activities of bioactive peptides against diabetes and obesity.

  • SGLT2 inhibitors as dual therapeutic targets for cardiovascular and renal health.

  • Biobased nanomaterials and rhizobacteria for sustainable plant growth.

  • CAR-T therapy in oral squamous cell carcinoma: Current innovations and future prospects.

Conclusion

Dr. Inamul Hasan Madar exemplifies excellence in translational medicine, combining cutting-edge cancer research with dedicated academic mentorship. His impactful publications, international collaborations, and leadership in oncology research position him as a transformative figure in biomedical sciences. Through his expertise in proteogenomics and bioinformatics, he continues to advance precision medicine while inspiring the next generation of medical researchers.

Dr.J.Brintha Jei | Dentistry | Best Researcher Award

Published on by Academic Excellence

Dr. J. Brintha Jei | Dentistry | Best Researcher Award

Dr. J. Brintha Jei | Dentistry | SRM Dental College | India

Dr. J. Brintha Jei is a distinguished dental professional and academician with expertise in Prosthodontics and Periodontics. She began her journey in dentistry by earning her BDS degree with distinction from Rajas Dental College under The Tamil Nadu Dr. M.G.R. Medical University in 2005. Pursuing her passion further, she completed her MDS in Prosthodontics from Vinayaka Missions Shankaracharya Dental College in 2009. With over 15 years of academic and clinical excellence, Dr. Brintha is currently serving as Associate Professor in the Department of Prosthodontics at SRM Dental College, Ramapuram. Her career is marked by outstanding contributions to teaching, patient care, research, and innovation. She has authored more than 50 research papers in reputed international and national journals, written textbook chapters, and holds two patents. Dedicated to professional service, she is actively involved in dental societies, peer reviewing, and conference organization, while also pursuing her Ph.D. in Dentistry.

Author Profiles

Orcid | Google Scholar

Education

Dr. J. Brintha Jei has pursued her academic journey with consistent dedication and academic brilliance. She completed her undergraduate studies at Rajas Dental College, affiliated with The Tamil Nadu Dr. M.G.R. Medical University, in 2005, graduating with distinction and securing top honors in Periodontics. Recognizing her aptitude for advanced learning, she pursued her postgraduate education in Prosthodontics at Vinayaka Missions Shankaracharya Dental College, completing her MDS in 2009. Her education has been strongly rooted in both theoretical knowledge and practical training, laying a solid foundation for her career as a clinician, researcher, and academician. Currently, she is advancing her scholarly pursuits through a Ph.D. program in Dentistry, reflecting her commitment to lifelong learning and research. Her educational journey showcases a blend of academic excellence, specialization in clinical dentistry, and innovation, positioning her as a role model in the dental field.

Experience 

With more than 15 years of professional expertise, Dr. J. Brintha Jei has made significant contributions to dentistry through teaching, clinical practice, and research. She is presently an Associate Professor in the Department of Prosthodontics at SRM Dental College, Ramapuram, where she mentors undergraduate and postgraduate students. Her teaching extends beyond the classroom, with hands-on workshops, pre-conference courses, and clinical demonstrations that provide students with practical insights into modern prosthodontic practice. Clinically, she is renowned for her precision and patient-centered approach in restorative and prosthodontic treatments. Alongside academics, she has published extensively in reputed international journals, authored textbook chapters, and holds patents that highlight her innovative mindset. She has delivered guest lectures at national and state conferences and has actively organized scientific programs, including international, national, and state-level conferences. Her multifaceted experience reflects her leadership in advancing dental education, clinical care, and interdisciplinary collaboration.

Awards and Honors

Dr. Brintha’s career is decorated with academic achievements, professional recognition, and research contributions. She graduated with distinction during her undergraduate studies, securing top honors in Periodontics, which highlighted her academic brilliance early on. Over the years, she has received recognition for her scholarly publications, with her research being featured in PubMed, Scopus, and Web of Science-indexed journals. Her contributions to innovation in dentistry are evident through two patents, underscoring her commitment to advancing clinical solutions. As an active member of professional bodies, she has earned key leadership roles, such as Executive Committee Member of the Indian Prosthodontic Society – Tamil Nadu & Pondicherry Branch and Joint Secretary of the Indian Society of Prosthodontics – Restorative – Periodontics (ISPRP). In addition, her role as a peer reviewer for reputed journals further demonstrates the respect she commands in the academic community. Her honors reflect her commitment to excellence in dentistry.

Research Focus

Dr. J. Brintha Jei’s research focus lies at the intersection of clinical excellence, innovation, and interdisciplinary collaboration in dentistry. Her primary research interests include prosthodontics, restorative dentistry, and periodontics, with an emphasis on improving patient care through advanced treatment methodologies. She is passionate about material science, digital dentistry, and innovative prosthodontic techniques that enhance oral rehabilitation outcomes. Her contributions extend to exploring implant dentistry, minimally invasive approaches, and aesthetic restorative practices. With more than 50 publications indexed in international databases, her work has contributed to the global pool of dental research, offering valuable insights for clinicians and academicians alike. Beyond publishing, she has written textbook chapters and filed patents, translating her research into practical applications. Currently pursuing her Ph.D., Dr. Brintha continues to expand her research scope, fostering innovation that bridges clinical needs with cutting-edge technology to improve dental care outcomes worldwide.

Publications 

  • Comparative analysis of prosthetic materials in restorative dentistry.

  • Evaluation of implant-supported prostheses for edentulous patients.

  • Advances in digital workflows for prosthodontic rehabilitation.

  • Biocompatibility of dental materials in clinical applications.

  • Clinical outcomes of full-mouth rehabilitation in compromised patients.

  • Textbook contributions on prosthodontics and restorative dentistry.

  • Molecular insights into periodontal health and restorative practices.

  • Innovation in maxillofacial prostheses for rehabilitation.

  • Trends in prosthodontics: A global research perspective.

  • Systematic reviews in restorative and prosthetic dental care.

Conclusion

Dr. J. Brintha Jei exemplifies excellence in dentistry through her achievements as a clinician, academician, and researcher. Her career reflects a balance of patient care, teaching, and groundbreaking research, making her a valuable contributor to the advancement of prosthodontics and dentistry as a whole. With her ongoing Ph.D. and her leadership roles in professional societies, she continues to inspire future dental professionals. Her scholarly output, innovation, and dedication to interdisciplinary collaboration strengthen her candidacy for recognition in academic and clinical dentistry.

Sasikumar Kuppusamy | Chemistry | Best Researcher Award

Published on by Academic Excellence

Mr. Sasikumar Kuppusamy | Chemistry | Best Researcher Award

Mr. Sasikumar Kuppusamy | Chemistry | Sacred Heart College Autonomous | India

Dr. Kuppusamy Sasikumar, Ph.D., is a dedicated researcher in the Department of Chemistry at Sacred Heart College (Autonomous), affiliated with Thiruvalluvar University, Tamil Nadu, India. With a strong academic foundation and extensive research expertise, he specializes in renewable energy, nanostructured materials, dye-sensitized solar cells, photocatalytic hydrogen production, and environmental chemistry. His doctoral work, “Tailoring Nanostructured Materials for Enhanced Performance in Renewable Energy Applications,” focuses on advanced material design for energy conversion and storage. He has collaborated with premier research institutes such as IIT Palakkad, NCL Pune, and Madurai Kamaraj University, gaining exposure to cutting-edge scientific techniques. Dr. Sasikumar has published impactful research in international journals and presented at prestigious conferences, earning recognition for his innovative approaches. A mentor to budding scholars, he has supervised multiple postgraduate and MPhil students. His vision is to harness chemistry-driven innovation to address global energy and environmental challenges, contributing to sustainable scientific progress.

Author Profiles

Orcid | Google Scholar

Education

Dr. Kuppusamy Sasikumar’s educational journey reflects his deep commitment to chemistry and interdisciplinary research. He began with a B.Sc. in Chemistry from Thiruvalluvar University, followed by an M.Sc. in Chemistry from Periyar University, Salem, India, where he developed strong foundations in analytical and materials chemistry. He advanced to an M.Phil. in Chemistry at Thiruvalluvar University, focusing on applied nanostructured materials. His doctoral studies at Sacred Heart College, under Thiruvalluvar University, further elevated his expertise. His Ph.D. thesis, “Tailoring Nanostructured Materials for Enhanced Performance in Renewable Energy Applications,” explores vanadium-doped ZnO and silver-based nanocomposites for solar cells, supercapacitors, and photocatalysis. He also underwent advanced training in thin-film and DSSC fabrication at the National Chemical Laboratory (NCL), Pune with Prof. C.S. Gopinath, broadening his technical proficiency. This educational progression has equipped him with both theoretical knowledge and experimental skills, shaping him into a capable scientist in sustainable energy and material science.

Experience

Dr. Sasikumar has gained rich experience in advanced material synthesis, energy applications, and academic mentorship. During his Ph.D. research at Sacred Heart College (2019–2025), he specialized in synthesizing and characterizing nanostructured materials, including vanadium-doped ZnO and silver-based composites for solar and photocatalytic applications. His hands-on expertise spans solution combustion, sol-gel, hydrothermal methods, and thin-film fabrication techniques such as spray coating, spin coating, and doctor blade methods. He has worked on several funded research projects, including UGC Minor Research Project, Don Bosco Research Grant, and Fr. Carreno Research Grant, contributing significantly to energy material innovations. As a mentor, he guided postgraduate and MPhil students in renewable energy-focused projects, fostering research leadership. He has presented findings at national and international conferences, winning recognition such as Best Poster Award at ICCSN 2019 (VIT, Vellore). His collaborations with IIT Palakkad, NCL Pune, and other reputed institutions highlight his engagement with interdisciplinary and applied scientific research.

Awards and Honors

Throughout his academic and research career, Dr. Kuppusamy Sasikumar has received recognition for his outstanding contributions in chemistry and renewable energy research. He has been awarded multiple institutional research grants, including the UGC Minor Research Project, Don Bosco Research Grants, and the Fr. Carreno Research Grant, reflecting trust in his innovative scientific pursuits. His research presentations have been acknowledged at international platforms, notably with the Best Poster Award at the International Conference on Chemical Sciences and Nanomaterials (ICCSN-2019) at VIT, Vellore. His participation in prestigious conferences, including ICETC 2020, IC-RAAM 2019, and SMART 2020, demonstrates his active engagement in global scientific discussions. In addition, his collaborative projects with premier institutes such as IIT Palakkad and NCL Pune underline his contribution to interdisciplinary research. These honors highlight his potential as a rising researcher in chemistry, committed to impactful scientific solutions addressing energy and environmental challenges.

Research Focus

Dr. Sasikumar’s research is centered on renewable energy materials, nanotechnology, and environmental chemistry. His work explores the synthesis and application of nanostructured materials for dye-sensitized solar cells (DSSC), supercapacitors, and photocatalytic hydrogen production. He focuses on tailoring the structural, electronic, and optical properties of advanced materials such as vanadium-doped ZnO, silver-based composites, and perovskite oxides, enhancing their efficiency for energy conversion and storage. He has developed expertise in thin-film fabrication for photo- and electrocatalytic applications, contributing to sustainable clean energy technologies. His research further extends to photo(electro) catalysis and environmental remediation, with innovations in hazardous dye degradation and water splitting for green hydrogen generation. His collaborations with IIT Palakkad, NCL Pune, and other reputed institutes have strengthened his interdisciplinary approach. Dr. Sasikumar’s long-term vision is to advance affordable, scalable, and environmentally friendly energy solutions through material science, bridging the gap between laboratory innovation and societal applications.

Publications

  1. Fuel Influenced Nanorod to Nanosphere Transformation of Vanadium doped ZnO for Dye-Sensitized Solar Cells.

  2. Natural Carbon Template on Ag-ZnO Nanocomposites for Supercapacitor, Hydrogen Production & Antifungal Activity.

  3. Structure Directing Amine Mediated Synthesis of Mn Doped ZnO Microrods for Dye Degradation.

  4. Tuning Structural & Magnetic Properties of SrSnO3 Nanorods for Enhanced DSSC Performance.

  5. Influence of Blocking Layer on Hf and V Doped Perovskite SrSnO3 for DSSCs.

  6. 3D CoMoO4 Nanoflake Arrays for Enzyme-less Electrochemical Glucose Sensors.

  7. Scalable Thin-Film TiO2 Membranes for Hydrogen Production via Water Splitting (Under Construction).

Conclusion

Dr. Kuppusamy Sasikumar is an emerging researcher whose work in chemistry bridges renewable energy, nanomaterials, and environmental sustainability. His academic background, practical expertise, and impactful publications highlight his ability to contribute to global energy solutions. With a commitment to mentoring and interdisciplinary collaboration, he represents the next generation of scientists driving sustainable innovation.

Syed Aasim Syed Nasir | Medicine | Excellence in Research

Published on by Academic Excellence

Mr. Syed Aasim Syed Nasir | Medicine | Excellence in Research

Mr. Syed Aasim Syed Nasir | Medicine | Tbilisi State Medical University | Georgia

Syed Aasim Syed Nasir is a dedicated fourth-year medical student at Tbilisi State Medical University, Georgia, committed to advancing medical research and clinical practice. His academic journey is complemented by extensive research contributions in cardiology, oncology, infectious diseases, and orthopedic surgery. With a growing publication record in reputed journals and conferences, he demonstrates strong skills in investigation, methodology, and medical writing. He has actively presented case reports, systematic reviews, and clinical studies at international platforms, earning recognition for his innovative insights. Beyond research, Syed Aasim is involved in leadership roles within medical organizations, fostering academic collaboration among peers worldwide. His internships and observerships in Dubai and Nigeria further enriched his exposure to diverse healthcare systems. Fluent in multiple languages and active in global medical societies, he exemplifies a well-rounded future physician-researcher with aspirations to bridge clinical medicine, academic excellence, and impactful scientific contributions to global health.

Author Profile

Orcid

Education

Syed Aasim Syed Nasir began his educational journey at Our Own English High School, Sharjah, UAE (2007–2019), where he developed a strong academic foundation. He then pursued his higher education at Velammal Vidhyashram School, Chennai, excelling in the sciences and preparing for a career in medicine. In 2021, he enrolled at Tbilisi State Medical University – School of Medicine, Georgia, where he is currently a Doctor of Medicine candidate. His education extends beyond formal coursework, as he participates in research training, medical writing, and scientific presentations at both national and international levels. His certifications in PALS, First Aid, CPR, ACLS, and BLS (in progress) add clinical preparedness to his academic excellence. Actively engaged in self-directed learning, he complements his curriculum with research in cardiology, oncology, and obstetrics, bridging classroom knowledge with real-world medical applications, shaping him into a future physician-scientist of global relevance.

Experience

Syed Aasim’s experience spans clinical exposure, research collaborations, leadership, and volunteerism. He completed observerships at Zulekha Hospital, Dubai, gaining insights into multidisciplinary patient care, and undertook a Psychnovation Neuroscience Internship, Nigeria, enhancing his research and clinical interpretation skills. He has served as a part-time researcher with the International Journal of Clinical Research (IJCR) and contributed to cardiology projects within IJCR Research Working Group. His leadership roles include General Secretary of ClinNova International, PR Team Member of IJCR Conference, Judiciary Council Member at GIMSOC, and University Head Representative. He also actively participated in Project IMG (USA) as a Unity Agent, furthering international student collaboration. His experiences combine academic rigor with hands-on exposure to clinical medicine, surgical case analysis, systematic reviews, and patient-centered research. These engagements reflect his commitment to developing as a medical leader, researcher, and clinician with both local and international impact.

Awards and Honors

Though early in his career, Syed Aasim has already earned recognition in multiple academic and professional avenues. His posters and case reports have been accepted and presented at high-impact platforms such as the Royal Society of London (2025) and the European Hip Society Congress, Thessaloniki, Greece (2025). His research on oncology, orthopedics, cardiology, and obstetrics has been acknowledged in international medical conferences, highlighting his ability to address complex diagnostic and therapeutic challenges. His selection as Georgia Ambassador for IJCR (2024–2025) underscores his leadership in research dissemination. Additionally, his active participation in medical student societies such as GIMSOC, SSSG, IASSS, and ClinNova International showcases his growing influence in academic medicine. These honors reflect both academic excellence and his proactive approach to advancing collaborative medical research. His consistent recognition in prestigious forums demonstrates his trajectory toward becoming a globally respected physician-researcher in medicine.

Research Focus

Syed Aasim’s research focuses on advancing clinical medicine through a multidisciplinary approach. His work spans oncology, cardiology, orthopedics, neurology, infectious diseases, and obstetrics/gynecology, reflecting his commitment to solving pressing healthcare challenges. He has investigated glioblastoma surgical outcomes, pharmacological mechanisms of UV-induced skin mutations, rheumatological impacts on cardiovascular health, and surgical complexities in gynecological disorders. His systematic reviews and meta-analyses address critical gaps in evidence-based medicine, such as hip arthroplasty, meniscal tear management, and cardiotoxicity biomarkers in cancer patients. He also explores therapeutics in infectious disease management, contributing reviews on measles outbreaks and innovative treatment strategies. His interest in women’s health and perinatal care is reflected in ongoing studies on melatonin supplementation in pregnancy and heart failure outcomes in women versus men. With a balance between clinical case reports, systematic reviews, and mechanistic research, his focus lies in generating translational insights that directly impact patient care and public health.

Publications

  1. A Diagnostic Chameleon: Genital Tuberculosis Mimicking Ovarian Malignancy – Case Report.

  2. Uterine Didelphys with OHVIRA Syndrome: Diagnostic and Surgical Challenges.

  3. Navigating the Pharmacological Landscape of UV-Induced Mutations in Skin Carcinogenesis.

  4. Comprehensive Review of Measles: Outbreak Trends, Clinical Manifestations, and Therapies.

  5. Glioblastoma Surgery: Comparative Study of Resection Degree and Survival Results.

  6. Rheumatoid Arthritis and Cardiovascular Mortality Trends in Postmenopausal Women.

  7. Glioblastoma Multiforme Surgery: Comparative Survival Investigation – IJCR 2024.

  8. Arthroscopic Partial Meniscectomy vs Exercise Therapy for Meniscal Tear: Systematic Review.

  9. Short Stem vs Standard Stem Total Hip Arthroplasty: A Systematic Review.

  10. Melatonin Supplementation in Pregnant Women: Neonatal Brain Maturation Study (In Progress).

  11. Impact of SGLT2 Inhibitors on HFpEF Outcomes: Gender-Based Analysis (In Progress).

  12. Rapid-Onset Obesity with Hypothalamic Dysfunction: Comprehensive Review (In Review).

  13. Infective Endocarditis Post-TAVR vs SAVR: A Comparative Study (In Review).

  14. NT-ProBNP/BNP vs Troponins in Chemotherapy-Induced Cardiotoxicity Detection (In Progress).

  15. Impact of Hydrotherapy in Sports Medicine (In Progress).

Conclusion

Syed Aasim Syed Nasir embodies the qualities of a future physician-scientist: rigorous academic training, international exposure, leadership in medical organizations, and impactful research contributions across diverse medical domains. His growing portfolio of publications, presentations, and leadership roles underscores his ability to bridge clinical practice and academic medicine. With a strong commitment to innovation and patient-centered research, he is positioned to make significant contributions to medicine and global healthcare. His trajectory reflects not only individual excellence but also the potential to influence future medical research and practice on a global scale.

 

hassan noorbazargan | Immunology | Best Researcher Award

Published on by Academic Excellence

Dr. hassan noorbazargan | Immunology | Best Researcher Award

Dr. hassan noorbazargan | Immunology | Carbon Technologies LLC | Oman 

Dr. Hassan Noorbazargan is a highly accomplished researcher specializing in biotechnology, immunology, and molecular diagnostics. He earned his Ph.D. in Medical Biotechnology from Shahid Beheshti University of Medical Sciences, Iran, where his doctoral work focused on the design and validation of advanced PCR assays for detecting HIV. His career reflects a strong combination of academic excellence and industrial expertise, spanning molecular diagnostics, vaccine production, recombinant protein development, and nanobiotechnology. Dr. Noorbazargan has held prominent roles at Carbon Technologies Co., ROJE Technologies, and the Pasteur Institute of Iran, where he contributed significantly to diagnostic assay development and vaccine quality control. His research contributions have led to impactful publications on nanocarriers, drug delivery, and novel therapeutic strategies for infectious diseases and cancer. Dedicated to advancing biotechnology and immunology, Dr. Noorbazargan continues to shape the scientific community with his innovative work, quality leadership, and pursuit of translational research.

Author Profiles

Orcid | Google Scholar

Education 

Dr. Hassan Noorbazargan pursued his Ph.D. in Biotechnology at Shahid Beheshti University of Medical Sciences, where he achieved a perfect GPA. His doctoral thesis focused on the design, development, and application of TaqMan real-time PCR for qualitative and quantitative detection of HIV, demonstrating his expertise in molecular diagnostics. Prior to this, he earned his M.Sc. in Microbiology from Islamic Azad University of Lahijan, where his thesis involved cloning and expression of the HCV core+1 protein in mammalian cells, highlighting his interest in virology and genetic engineering. He also completed his B.Sc. in Microbiology from the same university, where he developed a strong foundation in immunology, biochemistry, and cell biology. Through his academic journey, he undertook multiple research assistantships in microbiology and biotechnology labs, which helped refine his practical laboratory expertise. His educational achievements underline a consistent pursuit of excellence and research-driven learning.

Experience

Dr. Hassan Noorbazargan brings extensive experience in both academia and industry, specializing in diagnostics, vaccines, and nanobiotechnology. Currently serving as Senior Researcher & QC Head at Carbon Technologies Co., Muscat (2024–Present), he leads diagnostic kit validation for infectious diseases and ensures regulatory compliance. From 2019–2024, as Head of R&D at ROJE Technologies, he developed PCR assays for HIV, Hepatitis, and Influenza while managing technology transfer and GMP compliance. Earlier, he was a Senior R&D Specialist at Sinaclon, focusing on scaling molecular reagents and diagnostic kits. At the Pasteur Institute of Iran, he contributed as a Senior Scientist in BCG vaccine production and later as Scientific Advisor in vaccine development. His career also includes supervisory roles in clinical diagnostics and hands-on experience as a hospital lab technician. With a proven record in assay development, recombinant proteins, and nanocarriers, Dr. Noorbazargan continues to bridge research with translational healthcare solutions.

Awards and Honors

Throughout his career, Dr. Hassan Noorbazargan has earned recognition for his academic and research excellence in biotechnology and immunology. He successfully completed his Ph.D. with distinction at Shahid Beheshti University of Medical Sciences, where his groundbreaking work on HIV molecular detection positioned him as a leading scholar in molecular diagnostics. His innovative publications on nanocarriers, drug delivery systems, and novel therapeutic strategies for cancer and infectious diseases have been widely cited, reflecting their significant impact on the scientific community. He has also been acknowledged for his leadership in R&D roles, particularly in vaccine development and molecular assay validation, where his contributions directly influenced product innovation and clinical applications. In addition, Dr. Noorbazargan has participated in global training programs offered by WHO Academy, IAVI, Coursera, and edX, further strengthening his expertise. His ongoing pursuit of excellence and translational research has earned him recognition as a promising researcher in biotechnology and immunology.

Research Focus

Dr. Hassan Noorbazargan’s research is deeply rooted in immunology, nanobiotechnology, and molecular diagnostics. His focus lies in developing advanced diagnostic assays, nanocarrier-based drug delivery systems, and recombinant proteins for therapeutic and preventive medicine. A significant part of his work addresses infectious diseases such as HIV, Hepatitis, and COVID-19, where he has designed and validated cutting-edge PCR and ELISA-based assays for accurate detection. Beyond infectious diseases, his research explores innovative cancer therapies using niosomes, nanogels, and metal-organic frameworks for targeted and site-specific drug delivery. His publications highlight enhanced antibacterial, anticancer, and anti-metastatic strategies through engineered nanostructures, offering breakthroughs in precision medicine. He also contributes to vaccine research, optimizing immunogenicity assays and quality systems to improve vaccine safety and efficacy. By integrating molecular biology, immunology, and biotechnology, Dr. Noorbazargan’s research strengthens the bridge between laboratory innovation and clinical application, ultimately advancing global healthcare outcomes.

Publications

  • Narrative review on traditional medicine options for COVID-19 treatment.

  • Curcumin-loaded niosome nanocarriers for breast cancer therapy.

  • Ciprofloxacin-encapsulated niosomes for enhanced antibacterial activity.

  • Doxycycline-loaded niosomal formulation for prostate cancer treatment.

  • Niosome-loaded selenium nanoparticles for antibacterial and anticancer activities.

  • Folate-conjugated nanogels encapsulating oxaliplatin for colorectal cancer therapy.

  • Silver nanoparticles from Juniperus chinensis with anticancer properties.

  • Cefazolin-encapsulated UIO-66-NH2 nanoparticles against resistant S. aureus.

  • Folate-targeted curcumin-loaded niosomes for breast cancer treatment.

  • Biogenic AgNPs from Artemisia oliveriana for lung cancer therapy.

  • Engineered UIO-66 MOF delivering curcumin for breast cancer cells.

  • Super magnetic niosomal nanocarriers for breast cancer therapy.

Conclusion

Dr. Hassan Noorbazargan is a promising scientist whose research combines immunology, molecular diagnostics, and nanomedicine to address critical challenges in infectious diseases and cancer. With a balance of academic achievements, industrial expertise, and impactful publications, he stands as a strong candidate for global recognition in biomedical research.

 

Kiran Kharsodiya | Immunology | Women Researcher Award

Published on by Academic Excellence

Dr. Kiran Kharsodiya | Immunology | Women Researcher Award

Dr. Kiran Kharsodiya | Immunology | Mody University of Science and Technology | India

Kiran Kharsodiya is a dedicated Research Scientist and Microbiologist with over eight years of experience in clinical, pharmaceutical, and microbiological research. Currently serving as Project Research Scientist II under the ICMR-CAR-MEDTECH Project at St. John’s Research Institute, Bengaluru, Kiran has made impactful contributions in designing and executing large-scale intervention and medical device trials. His expertise lies in microbiological examination, molecular analysis, and the study of host-inflammatory pathways. Kiran holds a strong research background supported by multiple peer-reviewed publications in international journals, reflecting his commitment to advancing medical science. His doctoral research at Mody University focuses on microbiological and molecular analysis of abnormal vaginal discharge and its pathophysiological effects, bridging microbiology and women’s health. A recipient of CSIR-NET qualification in 2024, Kiran exemplifies innovation, critical thinking, and leadership in translational research. His collaborative approach and scientific rigor continue to shape impactful research outcomes with real-world clinical applications.

Author Profiles

Orcid | Google Scholar

Education

Kiran Kharsodiya has pursued a strong academic foundation in microbiology and life sciences, which has shaped his career in biomedical research. He is currently completing his Doctor of Philosophy (PhD) at Mody University, India, where his thesis focuses on “Microbiological Examination and Molecular Analysis in Abnormal Vaginal Discharge and Comparative Analysis of its Pathophysiological Effect.” His PhD integrates molecular biology with clinical microbiology to explore diagnostic and therapeutic strategies in women’s health. Kiran earned his Master of Science (Microbiology) degree from Devi Ahilya University, Indore, India, where he specialized in advanced microbiological techniques and clinical research applications. He also completed a Bachelor of Science (Industrial Microbiology) from the same university, where his academic excellence and research curiosity laid the foundation for his career. Complementing his education, he successfully qualified the prestigious CSIR-NET exam in 2024, showcasing his academic excellence and research potential.

Experience

Currently working as Project Research Scientist II at St. John’s Research Institute, Bengaluru, under the ICMR-CAR-MEDTECH Project (2024–present), Kiran Kharsodiya brings extensive expertise in microbiology and clinical trial management. His role involves designing and executing large-scale pharmaceutical, medical device, and clinical trials, with a focus on ensuring regulatory compliance and high-quality data collection. He actively contributes to Phase III trials, large intervention efficiency studies, and the development of non-medical trial protocols. His ability to coordinate daily operations, collaborate with multidisciplinary teams, and analyze clinical trial data demonstrates his strong leadership in research environments. Kiran is also skilled in publishing and disseminating research findings through scientific journals and conferences, reinforcing his contributions to the broader scientific community. With more than eight years of research experience, he has developed a reputation for innovation, scientific precision, and problem-solving, contributing significantly to advancing biomedical and microbiological research in India and beyond.

Awards and Honors

Throughout his career, Kiran Kharsodiya has consistently demonstrated academic excellence and research dedication, earning several notable distinctions. His most recent achievement includes qualifying the prestigious CSIR-NET examination in 2024, a highly competitive recognition that reflects his advanced scientific knowledge and potential for research leadership. His contributions to translational microbiological and clinical research have also been acknowledged through multiple peer-reviewed publications, a testament to his innovation and dedication. Kiran has been invited to present his findings at national and international scientific conferences, highlighting the global relevance of his work. His collaborative research within multi-institutional projects, such as the ECGRI study on endometriosis and ovarian cancer, further underscores his recognition within the scientific community. These milestones, combined with his proven ability to integrate microbiology, molecular biology, and clinical research, establish him as a promising scientist whose work continues to be recognized for both academic rigor and societal impact.

Research Focus

Kiran Kharsodiya’s research focus lies at the intersection of microbiology, immunology, and women’s health. His PhD work emphasizes microbiological examination and molecular analysis of abnormal vaginal discharge, aiming to identify pathogenic flora, host-inflammatory responses, and their pathophysiological effects. This contributes to better diagnostic and therapeutic strategies for gynecological conditions. His studies also expand into the role of biomarkers, such as cytokines and microRNAs, in diseases like endometriosis and ovarian cancer, highlighting his interest in translational research. By integrating clinical microbiology, immunological pathways, and molecular diagnostics, Kiran seeks to improve early detection and intervention in reproductive health disorders. His work extends to exploring host-pathogen interactions, inflammation markers such as IL-6, IL-1β, TNF-α, and their predictive value in microbial infections. This research bridges fundamental microbiology with clinical applications, addressing pressing healthcare challenges. His long-term goal is to advance diagnostic tools and contribute meaningfully to global women’s healthcare solutions.

Publications

  • Protocol for a case–control study investigating the clinical phenotypes and genetic regulation of endometriosis in Indian women: the ECGRI study.

  • The relationship between melatonin 1-2 receptor expression in patients with epithelial ovarian cancer and survival.

  • Endometriosis in India: Analysing diagnostic delays, geographic variations, clinical phenotypes and associated characteristics from the ECGRI Study.

  • Predictive value of IL-6, IL-1β, TNF-α, and vaginal pH in diagnosing vaginal microbial infections: A host-inflammatory axis perspective.

  • Identification and characterization of pathogenic microbial flora associated with abnormal vaginal discharge: A microbiological examination study.

  • A pilot study of circulating microRNA-125b as a diagnostic & prognostic biomarker for epithelial ovarian cancer.

  • 2022-RA-195-ESGO miRNA-125b expression in epithelial ovarian cancer.

Conclusion

Kiran Kharsodiya is a dynamic researcher with strong expertise in microbiology, immunology, and clinical research, making significant contributions to women’s health and translational medicine. His blend of academic rigor, practical experience in large-scale trials, and impactful publications positions him as a promising leader in biomedical sciences. With a clear focus on innovation, collaboration, and clinical relevance, he continues to advance knowledge at the crossroads of microbiology and immunology, striving to improve diagnostic and therapeutic outcomes for global healthcare.

Karthikeyan Kesavan | Pharmacology | Best Researcher Award

Published on by Academic Excellence

Assoc. Prof. Dr. Karthikeyan Kesavan | Pharmacology | Best Researcher Award

Assoc. Prof. Dr. Karthikeyan Kesavan | Pharmacology | Department of Pharmacy, Guru Ghasidas University | India

Dr. Karthikeyan Kesavan is an accomplished academic and researcher serving as an Associate Professor in the Department of Pharmacy at Guru Ghasidas Vishwavidyalaya, Bilaspur. With a Ph.D. in Pharmaceutics from IIT-BHU and postdoctoral research experience at the University of Iowa under the DBT-GETin Fellowship, he has established himself as an expert in nanopharmaceuticals and ocular drug delivery. His research integrates nanotechnology with pharmaceutics to design innovative formulations for treating complex ocular and infectious diseases. Dr. Kesavan has guided Ph.D. and postgraduate scholars, published extensively in high-impact journals, authored influential book chapters, and holds multiple patents in novel drug delivery technologies. His consultancy projects also extend expertise in nanoformulations of natural metabolites for managing ocular diseases. With an H-index of 16 and growing international collaborations, Dr. Kesavan continues to bridge cutting-edge research with practical healthcare applications, contributing significantly to the advancement of pharmacology and pharmaceutical sciences.

Author Profiles

Orcid | Google Scholar

Education 

Dr. Kesavan’s educational journey reflects excellence and dedication to pharmaceutical sciences. He earned his Bachelor of Pharmacy degree, which laid the foundation for his research interests, before pursuing a Master of Pharmacy (M. Pharm) in Pharmaceutics from Bharathidasan University. His academic passion led him to the prestigious Indian Institute of Technology (BHU), Varanasi, where he obtained his Ph.D. in Pharmaceutics, specializing in novel drug delivery systems. To further strengthen his expertise, he completed postdoctoral research at the University of Iowa, USA, under the distinguished DBT-GETin Fellowship, where he gained advanced experience in nanotechnology-based ocular drug delivery. This exposure enhanced his global outlook and scientific rigor, allowing him to integrate diverse approaches into his work. His education uniquely positioned him to contribute to both academic and industry-level pharmaceutical innovations. Today, his academic background continues to influence his impactful research in nanopharmaceuticals, ocular therapeutics, and gene delivery strategies.

Experience

Dr. Kesavan has more than a decade of experience in academia, research, and international collaboration. As an Associate Professor at Guru Ghasidas Vishwavidyalaya, he has played a pivotal role in advancing pharmaceutics education and research. His career includes mentoring doctoral and postgraduate students, designing advanced curricula, and fostering multidisciplinary projects. His consultancy experience extends to developing nanoformulations from medicinal plant metabolites for ocular disease management, bridging academia and applied science. Internationally, his postdoctoral research at the University of Iowa refined his expertise in nanocarrier-mediated gene therapy and non-viral delivery systems. Dr. Kesavan has completed projects funded by UGC, including innovative work on chitosan-coated cationic nanoemulsions for ocular delivery. His professional contributions encompass guiding clinical relevance, managing funded projects, publishing in SCI-indexed journals, authoring influential book chapters, and securing multiple patents. His diverse roles highlight his leadership in pharmacological innovation and his ability to translate research into practical applications.

Awards & Honors 

Throughout his career, Dr. Kesavan has earned significant recognition for his contributions to pharmaceutics and drug delivery research. His selection for the prestigious DBT-GETin Fellowship enabled him to conduct postdoctoral research at the University of Iowa, expanding his international collaborations. He has been awarded UGC-BSR startup grants for innovative work in ocular nanopharmaceuticals, particularly chitosan-coated cationic nanoemulsions. His impactful research has led to multiple patent awards, including recognition for hybrid hydrogel systems and IoT-based health monitoring devices, demonstrating his interdisciplinary innovation. Beyond patents, his publications in high-impact journals and contributions to specialized book chapters highlight his scientific leadership. His role in guiding research scholars and his consultancy services further showcase his dedication to advancing pharmaceutical sciences. These honors not only validate his scientific excellence but also underscore his commitment to pioneering new frontiers in pharmacology and translating research into therapeutic solutions.

Research Focus

Dr. Kesavan’s research focus lies at the intersection of nanotechnology and pharmacology, with a special emphasis on ocular drug delivery systems. His investigations aim to overcome biological barriers by developing innovative nanocarriers, such as nanoemulsions, micelles, and nanocapsules, for improved treatment of eye diseases like glaucoma, uveitis, bacterial keratitis, and fungal infections. His work also explores gene therapy approaches using non-viral vectors for safer and more effective management of ocular disorders. In addition, his patents reflect his expertise in designing mucoadhesive, biocompatible systems that enhance therapeutic efficacy while reducing side effects. Expanding beyond ocular pharmacology, he has also contributed to cancer therapy and infectious disease research through nanocarrier-based formulations. By integrating pharmaceutical sciences with biotechnology and engineering, Dr. Kesavan’s research demonstrates translational value, bridging laboratory discoveries with clinical applications. His focus continues to advance the field of nanopharmaceuticals, ensuring patient-centered, innovative, and sustainable therapeutic solutions.

Publications

    • Healing efficiency of nystatin-loaded chitosan-guar gum-based nanocapsules in experimental fungal keratitis.

    • Tear-Driven Phase Transition Microemulsion for Ocular Delivery of Dexamethasone in Uveitis.

    • Cationic microemulsion of voriconazole for fungal keratitis treatment: in vitro and in vivo evaluation.

    • TPGS-Chitosan Conjugated Mucoadhesive Micelles of Brinzolamide for Glaucoma Therapy.

    • Cationic Chitosan/Pectin Nanocapsules of Moxifloxacin for Bacterial Keratitis Management.

    • Cationic Polyelectrolyte Nanocapsules of Moxifloxacin for Microbial Keratitis Therapy.

    • Phase Transition Microemulsion of Brimonidine Tartrate for Glaucoma Therapy.

    • Brinzolamide loaded chitosan-pectin mucoadhesive nanocapsules for glaucoma therapy.

    • Positively Charged TPGS-Chitosan Nanocapsules as Non-Viral Vector for Glaucoma Gene Therapy.

    • Topical Ocular Delivery of Nanocarriers: A Feasible Choice for Glaucoma Management.

    • Ocular SMEDDS of Prednisolone for Improved Uveitis Therapy .

    • Tamoxifen citrate loaded chitosan-gellan nanocapsules for breast cancer therapy.

    • Phase Transition W/O Microemulsions for Antibacterial Activity in Bacterial Keratitis.

    • Chitosan-Coated Microemulsions for Enhanced Dermal Clotrimazole Delivery.

Conclusion

Dr. Karthikeyan Kesavan exemplifies excellence in pharmacology through his pioneering research in nanopharmaceuticals, ocular drug delivery, and innovative therapeutic approaches. With a strong educational foundation, impactful teaching experience, and international collaborations, he has established himself as a leader in pharmaceutical research. His extensive publications, patents, and consultancy work highlight his contributions to both academic and industrial advancements. Dr. Kesavan’s dedication to addressing unmet medical needs through nanotechnology-driven solutions continues to shape the future of pharmacology, making him a highly deserving candidate for recognition in the field.

Olugbenga Oloruntola | Animal Biochemistry | Outstanding Scientist Award

Published on by Academic Excellence

Dr. Olugbenga Oloruntola | Animal Biochemistry | Outstanding Scientist Award

Dr. Olugbenga Oloruntola | Animal Biochemistry | Adekunle Ajasin University, Akungba Akoko | Nigeria 

Dr. Olugbenga David Oloruntola, is a distinguished Nigerian scholar and researcher in Animal Biochemistry and Nutrition. Currently a Senior Lecturer at the Department of Animal Science, Faculty of Agriculture, Adekunle Ajasin University, Akungba Akoko, Nigeria, he has built an impressive academic and professional career spanning teaching, research, and community development. With expertise in animal nutrition, biochemical interactions, and feed technology, he has significantly contributed to sustainable animal production. His pioneering work includes exploring natural feed supplements and alternative dietary formulations that improve animal health, growth, and productivity while addressing global food security challenges. Dr. Oloruntola’s dedication to scientific research is evident in his numerous publications in high-impact journals, collaborative projects, and mentorship of young scholars. Married with two children, he balances academic excellence with family and community service, making him a highly respected figure in agricultural science and animal biochemistry research.

Author Profiles

Orcid | Google Scholar

Education 

Dr. Oloruntola’s educational journey reflects his commitment to academic excellence and professional advancement. He earned his Ph.D. in Agricultural Biochemistry and Nutrition in 2016 from the Federal University of Technology, Akure, Nigeria. Prior to that, he obtained an MSc in Animal Production and Health from Abubakar Tafawa Balewa University, Bauchi, and a B.Agric in Animal Science and Production (2014) from Joseph Ayo Babalola University. His qualifications also include multiple Postgraduate Diplomas Animal Production and Health and Education both with distinction. He further holds an HND in Animal Health Technology, ND in Agricultural Technology, and international training certifications such as the International Diploma in Animal Feeds from Aeres Training Centre, Netherlands and Laboratory Quality Systems training from Texas A&M University, USA. His early academic foundation was laid at Oyemekun Grammar School and Federal College of Agriculture, Akure, equipping him with strong skills in agricultural and biochemical sciences.

Experience 

Dr. Oloruntola has accumulated extensive academic and professional experience spanning over two decades. He began his career as Assistant Production Manager at Ola Olu Farms, followed by teaching Agricultural Science in both secondary and higher institutions. His expertise in agricultural development was enhanced as a Community Facilitator with the State Fadama Coordinating Office, Ministry of Agriculture, Akure, where he contributed to rural agricultural projects. He then advanced into academia as a Lecturer at the Federal Polytechnic, Ado Ekiti, rising through the ranks while engaging in research and departmental leadership. Since 2017, he has been with Adekunle Ajasin University, where he currently serves as Senior Lecturer (Associate Professor PFQ, 2022) in the Department of Animal Science. He teaches undergraduate and postgraduate courses in biochemistry, nutrition, and animal production, supervises research projects, and actively contributes to academic committees. His leadership and research experience have enriched Nigeria’s agricultural education and innovation.

Awards and Honors 

Dr. Oloruntola’s excellence in teaching and research has earned him notable awards and recognitions. He was honored with the Best Researcher of the Year Award (2015/2016) by the Agricultural Technology Department, Federal Polytechnic, Ado Ekiti, in recognition of his outstanding contributions to innovative agricultural science research. His international recognition includes the prestigious Orange Knowledge Program Fellowship (2019), awarded for advanced training in Animal Feeds at Aeres Training Centre International, Barneveld, Netherlands. These accolades underscore his commitment to advancing sustainable animal nutrition and biochemistry while strengthening international collaboration. Beyond these, he has received institutional recognition for academic excellence, student mentorship, and impactful research. His awards reflect not only his individual achievements but also his dedication to transforming agricultural practice in Nigeria and beyond. By integrating research with practical applications, he has consistently demonstrated leadership in the fields of animal biochemistry, nutrition, and sustainable livestock production.

Research Focus

Dr. Oloruntola’s research focuses on Animal Biochemistry and Nutrition, with particular emphasis on natural feed additives, alternative dietary formulations, and biochemical responses in livestock. His studies explore the use of plant-based supplements such as neem, pawpaw, bamboo, Alchornea cordifolia, and cocoa pod husks to improve growth performance, immunity, and oxidative stress resistance in poultry, rabbits, and pigs. His work also examines enzymatic supplementation, antioxidant mechanisms, and the biochemical indices of animals under dietary interventions. By integrating biochemistry with animal science, he provides evidence-based strategies to reduce reliance on conventional feed resources, thus enhancing food security and sustainable agriculture. His research has global relevance, addressing climate change, animal welfare, and the search for eco-friendly production systems. Through collaborations, high-impact publications, and supervision of postgraduate students, Dr. Oloruntola continues to shape the field of animal biochemistry, contributing significantly to innovations in livestock nutrition and sustainable animal agriculture.

Publications 

  • Neem, pawpaw and bamboo leaf meal dietary supplementation in broiler chickens: Effect on performance and health status.

  • Effect of feeding broiler chickens with diets containing Alchornea cordifolia leaf meal and enzyme supplementation.

  • Pawpaw leaf and seed meals composite mix dietary supplementation: Effects on broiler performance, caecum microflora and blood analysis.

  • Protective effect of soursop juice on oxidative stress in heat-stressed rabbits.

  • Effect of Alchornea cordifolia leaf meal and enzyme supplementation on growth, haematological and biochemical response of rabbits.

  • Effect of Alchornea cordifolia leaf meal inclusion and enzyme supplementation on rabbit performance and digestibility.

  • Effect of forages on performance, carcass cuts and haematological profile of weaner rabbits.

  • Effects of Myristica fragrans seed meal and Syzygium aromaticum leaf meal supplementation on broiler performance and oxidative status.

  • Replacement value of rumen liquor fermented cassava peels for maize in growing rabbit diets.

Conclusion

Dr. Olugbenga David Oloruntola is a visionary scholar whose expertise in Animal Biochemistry and Nutrition has made significant contributions to sustainable animal production and agricultural innovation. With strong educational foundations, extensive teaching and research experience, and impactful publications, he has demonstrated excellence in addressing food security, livestock health, and environmental sustainability. His recognition through national and international awards further validates his role as a leader in agricultural science. As a mentor, researcher, and academic leader, Dr. Oloruntola continues to inspire future generations of scientists while advancing research that bridges science and practice in animal biochemistry.

 

Jiaming Ni | Chemistry | Best Researcher Award

Published on by Academic Excellence

Dr. Jiaming Ni | Chemistry | Best Researcher Award

Dr. Jiaming Ni | Chemistry | Nanchang Hangkong University | China

Jiaming Ni, is a dedicated researcher specializing in two-dimensional (2D) materials with a strong focus on their applications in photocatalysis, gas sensing, and semiconductor technologies. With a solid foundation in materials science and engineering, he has advanced his expertise through rigorous academic and industrial experiences. From his early education in Vehicle Engineering to his doctoral research in Materials Science, Jiaming has consistently demonstrated persistence, curiosity, and innovation. His work spans density functional theory (DFT) simulations, heterostructure design, and semiconductor process improvement. Beyond his academic achievements, he has practical industry experience in semiconductor manufacturing and environmental protection technology, where he contributed to experimental design, process optimization, and performance evaluation. Known for his patient and detail-oriented approach, Jiaming is also an effective communicator with strong leadership experience, including serving as a university association president. His career objective is to further advance 2D materials research for practical industrial applications.

Author Profile

Google Scholar

Education 

Jiaming Ni began his academic journey at Nanchang University College of Science and Technology, where he pursued a four-year program in Vehicle Engineering. During his undergraduate years, he demonstrated strong leadership qualities, serving as president of the Tourism Association while maintaining a balance between academics and extracurricular activities. Building on this foundation, he advanced to the Guilin University of Electronic Technology, specializing in Microelectronic Packaging for his Master’s degree. His academic excellence was recognized with three scholarships, and he earned the distinction of delivering the Best Defense for his thesis. Currently, Jiaming is pursuing his Ph.D. in Materials Science at Universidad Autónoma de San Luis Potosí, where his research is centered on semiconductor materials, density functional theory applications, and the design of van der Waals heterostructures for advanced energy and sensing technologies. His continuous learning mindset also drives his self-study of semiconductor manufacturing processes and 2D material properties.

Experience

Jiaming Ni has cultivated a diverse career blending academic research with industrial applications. His early professional exposure came through project experiences at SDIC Xinjiang Lop Nur Potash Co., Ltd., where he worked on flotation process optimization and laboratory test investigations. He later collaborated with Shandong Runsheng Environmental Protection Technology Co., Ltd., planning experiments and analyzing water treatment processes. Transitioning into the semiconductor sector, Jiaming served as a Manufacturing Engineer at Semiconductor Manufacturing International Corporation (SMIC), where he was responsible for production planning, system testing, on-site management, and yield improvement in 12-inch fabrication facilities. Currently, he works at Guangzhou Yuexin Semiconductor Technology Co., Ltd. as a TD PIE engineer, focusing on online CP/CPK analysis, product flow optimization, anomaly handling, and yield enhancement. Complementing his industrial work, Jiaming is advancing his Ph.D. research on 2D materials, combining theoretical DFT studies with practical semiconductor technology, thereby bridging academic innovation with real-world industry needs.

Awards and Honors

Throughout his academic and professional journey, Jiaming Ni has consistently been recognized for his dedication and excellence. During his Master’s studies at Guilin University of Electronic Technology, he earned three prestigious scholarships, reflecting his strong academic performance and research potential. His commitment to excellence culminated in achieving the honor of delivering the Best Defense for his thesis, a distinction highlighting both his technical depth and communication skills. His leadership capabilities were acknowledged during his undergraduate years when he served as the President of the Tourism Association, showcasing his organizational and interpersonal abilities. In his professional career, Jiaming’s contributions in semiconductor manufacturing and process optimization have been recognized by his supervisors and project leaders, reinforcing his value as a team-oriented innovator. These accolades collectively underscore his capability to balance research excellence with leadership, making him a promising candidate for advancing the frontiers of materials science and semiconductor technologies.

Research Focus

Jiaming Ni’s research is centered on the design, simulation, and application of two-dimensional (2D) materials, particularly for energy and sensing applications. His work employs density functional theory (DFT) to investigate adsorption mechanisms, electronic properties, and catalytic performance of graphene, MoS₂, InSe, and their doped or heterostructure counterparts. A key area of his study involves van der Waals heterostructures for hydrogen production through photocatalysis, addressing the global challenge of clean energy. Additionally, he explores gas adsorption and sensing capabilities of doped 2D materials, targeting hazardous molecules such as SO₂, CH₄, and other small gases, with potential applications in environmental monitoring. Beyond theoretical modeling, his research extends into semiconductor manufacturing processes, where he contributes to yield improvement, flow optimization, and anomaly resolution. By combining computational modeling with practical semiconductor expertise, Jiaming bridges fundamental science and applied engineering, aiming to advance sustainable energy, environmental sensing, and next-generation electronic devices.

Publications

  1. Using van der Waals heterostructures based on InSe-XS₂ for efficient hydrogen production.

  2. Density-functional calculation of methane adsorption on graphene.

  3. Adsorption of small gas molecules on Fe, Ni, Co, and Cu-doped graphene: A DFT study.

  4. Adsorption of SO₂ gas molecules on B, N, P, and Al-doped MoS₂: A DFT investigation.

  5. Theoretical insights into sensing mechanisms of pure and doped graphene-based methane sensors.

Conclusion

Jiaming Ni is an accomplished and forward-looking researcher in the field of materials science and semiconductor technology, with a specialization in 2D materials and DFT-based modeling. His blend of strong academic background, industry experience, leadership roles, and innovative research focus positions him as a valuable contributor to the advancement of clean energy, environmental sensing, and semiconductor applications. His publications reflect deep expertise in computational chemistry and applied materials, making him a deserving candidate for recognition in the field of Chemistry and Materials Research.

Afra Wasama Islam | Medicine | Academic Excellence Award

Published on by Academic Excellence

Ms. Afra Wasama Islam | Medicine | Academic Excellence Award

Ms. Afra Wasama Islam | Medicine | Faculty of Medicine, Tbilisi State Medical University | Georgia

Afra Wasama Islam is a dedicated 5th-year medical student at Tbilisi State Medical University, Georgia, with a strong passion for clinical practice and medical research. She combines technical proficiency in clinical examination, surgical skills, and pharmacotherapy with advanced competencies in wet lab techniques such as ELISA, PCR, and microscopy. As the Chief Executive Officer of ClinNova International, Afra leads a team of over 70 individuals, demonstrating her leadership and management expertise alongside her academic achievements. She actively contributes to global medical communities through her involvement in research clubs, webinars, workshops, and scientific presentations. With publications in international journals and recognition for her work on gastrointestinal health, infectious diseases, and cardiovascular research, she is establishing herself as a promising medical researcher. Her diverse interests, multilingual abilities, and strong creative outlook further complement her vision of advancing healthcare research and practice on a global scale.

Author Profile

Orcid

Education 

Afra Wasama Islam is pursuing her Bachelor of Medicine, Bachelor of Surgery (MBBS) at Tbilisi State Medical University, Georgia, where she is currently in her 5th year of studies (2021–2027). Her academic journey reflects a strong commitment to excellence in both theoretical knowledge and hands-on training. She has acquired comprehensive exposure to medical history-taking, clinical examinations, pharmacotherapy, and advanced surgical procedures. Afra has further strengthened her academic foundation through certifications in Good Clinical Practice (GCP), NIH’s IPPCR course, Basic Surgical Skills, Basic and Pediatric Advanced Life Support, and Healthcare Communication. These achievements demonstrate her dedication to maintaining high standards in medical ethics, patient care, and research methodologies. Her education is also enriched by global exposure, as she participates in international webinars, workshops, and presentations, gaining cross-cultural medical perspectives. With her academic rigor and continuous learning, Afra is well-prepared to contribute significantly to clinical medicine and research innovation.

Experience

Afra’s professional experience highlights her dual strengths in clinical research and leadership. As the CEO of ClinNova International, she manages and mentors a team of 70+, leading global collaborations in medical research. She also serves as a Research Mentor at ClinAcademy and ClinNova International, nurturing future medical researchers. Her leadership extends to positions such as Head of the Creative Department at GCMER Georgia, Co-Head of Workshops at IJCR, and Secretary of the Social Media Chapter at YCC, where she has supervised and trained diverse teams. Afra has actively contributed to academic communities as a Webinar Host for SSSG and a Core Team member of the Research Club at TSMU. Beyond management, she has presented her research at multiple international conferences, covering topics from oncology to robotic surgery. This blend of organizational leadership, clinical knowledge, and academic research positions her as a versatile and impactful emerging medical professional.

Awards and Honors 

Afra Wasama Islam has been recognized for her academic excellence and scientific contributions through various awards and honors. She has presented her research at prestigious platforms such as Eternity (Tbilisi, Georgia), Pulmora, and the Royal Society of Medicine (UK), where her work on topics including lung cancer surgery, spinal cord injury, robotic mastectomy, and stroke prevention has gained significant attention. Her oral and poster presentations reflect her dedication to advancing clinical understanding and innovative practices in medicine. She has also been honored with leadership responsibilities across organizations like ClinNova International, IJCR, and GCMER, highlighting her role as a young leader in medical research. Afra’s certifications from renowned institutions, including the National Institute of Health (NIH) and Clinical Skills Centers, further reinforce her credibility. Her professional memberships with international medical societies showcase her global recognition and commitment to collaborative medical advancement.

Research Focus 

Afra Wasama Islam’s research focus integrates clinical medicine, public health, and translational science. She has explored diverse areas such as neuropsychiatric disorders (Depersonalization-Derealization Disorder), gastrointestinal health (FODMAP diets in IBS patients), and infectious diseases (human metapneumovirus and measles). Her cardiovascular research investigates the implications of L-carnitine and TMAO in heart complications, while her public health studies address zoonotic viral transmission and healthcare strategies. Beyond disease mechanisms, Afra is passionate about digital health, demonstrated in her work on smart inhalers for asthma and COPD, combining medicine with technological innovation. She has also contributed to research on surgical innovations, including robotic versus open mastectomy and thoracotomy versus minimally invasive surgery. This diverse portfolio reflects her forward-looking vision of bridging clinical practice, research, and digital healthcare solutions. With her strong multidisciplinary foundation, Afra aims to contribute to patient-centered healthcare, medical innovation, and global public health improvement.

Publications 

  1. Depersonalization-Derealization Disorder: Etiological Mechanism, Diagnosis and Management.

  2. Comparison of Impact of High vs. Low FODMAP Diet on Gut Flora in IBS Patients.

  3. Clinical Implications of L-Carnitine and Elevated TMAO in Cardiovascular Complications.

  4. Clinical Insights in Human Metapneumovirus Management and Prognosis.

  5. Potential Zoonotic Transmission of HKU5-CoV-2: Host Susceptibility & Public Health Risks.

  6. Comprehensive Review of Measles: Outbreaks, Clinical Manifestations & Therapies.

Conclusion

Afra Wasama Islam exemplifies the qualities of a future leader in medicine combining clinical acumen, innovative research, and effective leadership. With her international publications, research presentations, and executive experience in medical organizations, she has established herself as a promising young professional. Her focus on integrating clinical practice, research, and digital health innovation positions her to make impactful contributions to global healthcare. She is highly suitable for recognition under the Medicine Award, as her work reflects both academic excellence and dedication to advancing human health.